#PacBio's
Guilherme continues with a look at #PacBio's epigenetics analysis pipeline, combining methylation, chromatin accessibility & phasing for allele-specific insights.

Using MethBat for 5mC and Fiber-tools for 6mA, researchers can further analyze and interpret epigenetic data.

#ASHG26 #ASHG2026
October 21, 2026 at 4:59 PM
$PACB — PacBio's recent analyses covered strong short-term technical momentum against declining revenue and negative shareholder equity.

https://market-scanner.net/tickers/PACB.US

#ai #trading
PACB.US — AI analysis summary
Descriptive, non-directional summary of recent AI analyses.
market-scanner.net
October 16, 2026 at 12:32 PM
Clinical targeted sequencing is evolving. 🧬

Vega SPRQ-Nx makes HiFi sequencing more accessible with higher data output, lower DNA input & faster runs.

Explore applications in repeat expansions, HLA typing & more.

Download the HiFi Playbook: https://bit.ly/4wTy43t
October 15, 2026 at 5:05 PM
Microbial genomes are compact, but the questions are complex.

PacBio HiFi sequencing helps resolve microbial genomes and characterize communities. Vega with SPRQ-Nx makes high-resolution sequencing more scalable.

📖 Download the HiFi Playbook: https://bit.ly/4zJLPV4
October 8, 2026 at 3:54 PM
$PACB — PacBio's recent reports covered significant price momentum alongside declining revenue and negative profitability.

Stock price trading significantly above 50-day and 200-day SMAs. Latest quarter revenue decreased 1.9% year-over-year.

https://market-scanner.net/tickers/PACB.US

#ai #trading
PACB.US — AI analysis summary
Descriptive, non-directional summary of recent AI analyses.
market-scanner.net
September 30, 2026 at 6:20 PM
PacBio’s very expensive foray into short read sequencing is now officially over. 🙄

www.pacb.com/press_releas...
PacBio Completes Sale of Short-Read Sequencing Assets - PacBio
MENLO PARK, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the completion of the sale of sel...
www.pacb.com
February 2, 2026 at 5:18 PM
PacBio’s new SPRQ chemistry brings down the LR human genome to $500. Is it enough to move the needle (faster)?

sandiegomics.com/pacbio-sprq/
PacBio Brings Down Long Read Human Genome to $500
PacBio announced their new SPRQ long read sequencing chemistry ahead of ASHG. While it improves a couple of things, the headline is that it brings down the cost of a long read HiFi human genome to …
sandiegomics.com
October 29, 2024 at 6:36 PM
$BNGO - Bionano

Watching our industry : PacBio

PacBio Q3 2024 results.

PacBio's Q3 results reflect the [severe] H2 2024 downturn in the industry (save for Illumina).

www.pacb.com/press_releas...
November 25, 2024 at 9:48 PM
According to the AI, it seems that other scientific research domains (genetic profiling, precision medicine, etc) have advanced to a point where long-read technologies can be more fully utilized.

PacBio’s profitability focus + market trends could give portfolios a nice return in the future. ⏱️
November 28, 2024 at 6:37 AM
“Consumables are the single-use materials and kits essential for running sequencing experiments on PacBio’s instruments.”

Interesting…so with the release of their long-read sequencing machines, they are expanding their reach with customers.

Sounds promising…
November 28, 2024 at 6:37 AM
For those interested in PacBio's SPRQ-Nx chemistry and reusable SMRT Cells: in the Genome of Sweden project, we moved from 2 to 3 acquisitions per SMRT Cell in June. The results are impressive—we’re now approaching 400 Gb HiFi yield from a single SMRT Cell!
July 3, 2026 at 3:48 PM
These are beta test results of PacBio's reusable SMRT-cells, run on human blood DNA from the "Genome of Sweden" project. Results have been really impressive so far, with an average >250Gb per SMRT-cell over 2 acquisitions. We are now about to expand to 3 acquisitions
Sharing results from a beta test of PacBio’s SPRQ-Nx reusable SMRT cells using two acquisitions!

This increased SMRT cell throughput reduces sequencing costs for large human WGS projects.

#ESHG2026 #PacBio #ESHG
June 14, 2026 at 12:24 PM
Is there anyone who already started running PacBio's new SPRQ chemistry? Our Revio will be updated in a couple of weeks but I’m really curious to know how it’s working at other sites 🧪🧬
January 7, 2025 at 1:24 PM
Pretty cool! Ability to do long-read metagenomes is often limited by DNA input. PacBio's new SPRQ chemistry increases data output, reduces input req to 500ng. More importantly, the more you multiplex the less input you need. Multiplex 2 samples, req is 250ng and so on.

www.pacb.com/blog/lightin...
Lighting a SPRQ: How new Revio chemistry fuels innovative research - PacBio
New SPRQ chemistry for the Revio system is revolutionizing HiFi sequencing with increased efficiency, affordability, and reduced DNA input. Learn about its impact on research in rare diseases, cancer,...
www.pacb.com
February 20, 2025 at 1:55 AM
Join our Live Webinar! Zach Freeman, DVM, PhD, will discuss using Fiber-seq with PacBio's PureTarget™ for transgene insights. Plus, Emily Madden, PhD, will provide practical tips for getting started with Fiber-seq.

Register Now: https://app.livestorm.co/epicypher/combining-fiber-seq-and-puretarget
November 18, 2025 at 7:01 PM
Deadline Extended! 🧶 Unravel your epigenetics research!

Apply for PacBio's 2025 Epigenetics SMRT Grant Program! Win FREE Fiber-seq treatment, library prep, and sequencing to reveal layers of insights in one multiomic assay.

📝 Apply: https://programs.pacb.com/l/1652/2025-09-26/4587k8
October 30, 2025 at 3:01 PM
@sptlabtech.bsky.social has collaborated with PacBio to automate PacBio’s Kinnex full-length RNA-seq library prep on SPT’s firefly platform.
Validated at Seattle Children’s Genomics & Spatial Biology CoLab, the workflow improves reproducibility and scalability: bit.ly/4ianz63
November 20, 2025 at 2:08 PM
Can't help but wonder if Vega is possibly going to be PacBio's last grasp at market share. 28% drop in Q3 revenue... is Vega too little too late? Having additional competing tech is critical for the #genomics industry. Maybe this week is just getting to me in general...
November 8, 2024 at 5:15 PM
Some exciting professional news: Athena Diagnostics, Inc. developed an LDT using PacBio's PureTarget technology (my product!!) and HiFi sequencing on the Revio, which improves Ataxia Diagnostics for some of the most challenging genes in the human genome. Read the press release here: lnkd.in/g-ec-ECq
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
July 29, 2025 at 2:19 PM
These need a bit more workshopping; the longest mahmoudi sequence is missing bits, with 10k banding and lots of N patches; the chili sequence is similar, with more breaks.

It's been a while since I've looked at a chromosome larger than a gigabase with REPAVER; seems like it's still working okay.
May 29, 2026 at 1:44 PM